Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003131848 | SCV003814232 | uncertain significance | 3M syndrome 2 | 2022-07-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003294640 | SCV004007691 | uncertain significance | Inborn genetic diseases | 2023-04-05 | criteria provided, single submitter | clinical testing | The c.3892G>A (p.G1298S) alteration is located in exon 12 (coding exon 12) of the OBSL1 gene. This alteration results from a G to A substitution at nucleotide position 3892, causing the glycine (G) at amino acid position 1298 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |